Filter Results:
(351)
Show Results For
- All HBS Web
(351)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(351)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
- 06 Apr 2023
- Blog Post
Circularity in Denmark
Kalundborg Refinery’s second generation bioethanol production from wheat straw. We closed the day with an inspiring view of how this biotech hub will continue leading innovation in sustainable energy infrastructure as Kalundborg Utility... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract... View Details
Keywords: Sean Silverthorne
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging company and a VC-backed View Details
Keywords: by Susan Young
- 22 Feb 2022
- News
An Rx for Small Business Recovery
cluster concept pioneered by Michael Porter, the Bishop William Lawrence University Professor (Renewal Leave) at HBS, Mills argues that organizing a region’s small and large businesses around specialized industries—such as biotech in... View Details
Keywords: Deborah Blagg
- 10 Jun 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Cofounders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- 26 Jan 2021
- News
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
sharing how they were tapped to confront the COVID crisis. “On the sixth of May, I got a call from the Prime Minister asking me to take on this role,” said Bingham, who leads biotech investments as Managing Partner at SV Health Investors.... View Details
Keywords: Margie Kelley
- 10 May 2017
- Research & Ideas
Amazon Web Services Changed the Way VCs Fund Startups
cloud-based software and service companies, which could take advantage of AWS to decrease costs, versus others like biotechs that were less impacted by the new technologies. “The goal was to try and understand whether VCs were allocating... View Details
- 16 Feb 2004
- Research & Ideas
HBS Center Focuses on Europe
growth decisions facing Direvo, a young German biotech firm, when one of their partners suddenly wants to become an investor and the company expands both its customer and investor base in Europe and not just in Germany. Still a relatively... View Details
Keywords: by Cynthia Churchwell
- 01 Jun 2003
- News
Student Conferences, at a Glance
Jurvetson; Jeffrey C. Walker (MBA 1981), managing general partner, JPMorgan Partners; Stephen A. Schwarzman (MBA 1972), founding partner, president, & CEO, The Blackstone Group Fewer but better biotech companies are being funded with... View Details
- 20 Jul 2015
- Research & Ideas
Globalization Hasn’t Killed the Manufacturing Cluster
the federal government to create new clusters in the United States. He points to the rise of biotech in Harvard's backyard, which began despite government opposition in the 1970s. Clusters "tend to emerge much more organically, and they... View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Harvard Business School Supplement 107-049 Supplements the (A) case. Purchase this supplement: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107049 Monsanto: Realizing Biotech Value in Brazil Harvard Business School Case... View Details
Keywords: Martha Lagace
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even... View Details
Keywords: Sean Silverthorne
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details
Keywords: by James Heskett
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
next pandemic. As COVID taught us, the more we prepare now, the quicker we can get back to normal when the next pandemic hits. As I look back at Vaxess years, it has been fantastic to see life sciences grow at HBS and within the Boston View Details
- Web
Women on Boards: How Lara Druyan and Ann Lucena Are Shaping the Future of Corporate Leadership - Blog: RGE Report
“You need to be targeted; if you focus on too many things, you’re not focusing on anything.” Narrowing the field is always paramount, but it’s especially important when a company is in flux. As a director at Cerus Corporation—a biotech... View Details
- 19 Mar 2006
- Research & Ideas
Unlocking Your Investment Capital
Neither an asset's cost nor its size specifies its riskiness. For example, consider two assets, $1 billion of a single-drug biotech stock and $1 billion of U.S. Treasury bonds: Each has the same cost and size but they have radically... View Details
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his... View Details
- 08 Sep 2010
- First Look
First Look: September 8, 2010
for a cure; the doubts and obstacles he experiences along the way; and the current options Kremer faces, from returning home to spend time with family to founding a new biotech venture. Through this stark, realistic, and inspiring... View Details
Keywords: Sean Silverthorne
- 01 Jun 2007
- News
Mission Possible
“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately... View Details